Contemporary treatment approaches to primary immune deficiencies

shutterstock_1762529015 - image for Home page

Refined immunoglobulin replacement therapy improves humoral immunodeficiency real-world outcomes; learn to distinguish between these genetic conditions and the contemporary multidisciplinary approach to treatment

Learning objectives

You will learn:

  • Approaches to identifying patients who may have a primary immunodeficiency disorder and differential diagnoses for hypogammaglobulinaemia
  • Goals of treatment and a guideline-recommended approach to initial therapy
  • The key outcomes of clinical trials and real-world evidence demonstrating improved outcomes with the use of immune globulin subcutaneous (human) 20% solution as immunoglobulin replacement therapy.

To access this module, please register or login: